KIAA0922 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.774600E-01
Normal-vs-Stage2
2.870200E-01
Normal-vs-Stage3
2.732200E-01
Normal-vs-Stage4
2.696800E-01
Stage1-vs-Stage2
7.031800E-01
Stage1-vs-Stage3
8.776200E-01
Stage1-vs-Stage4
7.616200E-01
Stage2-vs-Stage3
1.470600E-01
Stage2-vs-Stage4
5.790800E-01
Stage3-vs-Stage4
8.152200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.877200E-01
Normal-vs-AfricanAmerican
2.954200E-01
Normal-vs-Asian
2.555600E-01
Caucasian-vs-AfricanAmerican
8.119200E-01
Caucasian-vs-Asian
2.982300E-03
AfricanAmerican-vs-Asian
4.122100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.808000E-01
Normal-vs-Female
2.928000E-01
Male-vs-Female
2.148000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.926400E-01
Normal-vs-Age(41-60Yrs)
2.900000E-01
Normal-vs-Age(61-80Yrs)
2.845000E-01
Normal-vs-Age(81-100Yrs)
2.829800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.944800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.978400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.501000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.696800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.424800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.112000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.829400E-01
Normal-vs-Daily Drinker
2.736000E-01
Normal-vs-Weekly Drinker
2.736400E-01
Normal-vs-Occasional Drinker
2.753200E-01
Normal-vs-Social Drinker
2.880800E-01
Non Drinker-vs-Daily Drinker
5.945600E-01
Non Drinker-vs-Weekly Drinker
5.887000E-01
Non Drinker-vs-Occasional Drinker
7.055000E-01
Non Drinker-vs-Social Drinker
8.063800E-01
Daily Drinker-vs-Weekly Drinker
9.958000E-01
Daily Drinker-vs-Occasional Drinker
9.135400E-01
Daily Drinker-vs-Social Drinker
3.676800E-01
Weekly Drinker-vs-Occasional Drinker
9.186000E-01
Weekly Drinker-vs-Social Drinker
3.588800E-01
Occasional Drinker-vs-Social Drinker
4.505800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.821600E-01
Normal-vs-Grade 2
7.723600E-01
Normal-vs-Grade 3
5.114000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.652600E-01
Grade 1-vs-Grade 3
3.027800E-01
Grade 1-vs-Grade 4
9.821600E-01
Grade 2-vs-Grade 3
3.202800E-01
Grade 2-vs-Grade 4
7.723600E-01
Grade 3-vs-Grade 4
5.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.989800E-01
Normal-vs-NonDiabetic
2.762200E-01
Diabetic-vs-NonDiabetic
9.132300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.650800E-01
Normal-vs-NoPancreatitis
2.846800E-01
Pancreatitis-vs-NoPancreatitis
2.303600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.874600E-01
Normal-vs-N1
2.861400E-01
N0-vs-N1
9.324400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.419400E-01
Normal-vs-TP53-NonMutant
2.866800E-01
TP53-Mutant-vs-TP53-NonMutant
7.194000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
